story of the week
Eculizumab Monotherapy Appears Effective for NMOSD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension
Mult. Scler. 2021 Sep 09;[EPub Ahead of Print], SJ Pittock, K Fujihara, J Palace, A Berthele, HJ Kim, C Oreja-Guevara, I Nakashima, M Levy, S Shang, M Yountz, L Miller, R Armstrong, DM WingerchukFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.